Dr. Cantu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-648-0921Fax+1 214-648-0952
Summary
- Dr. Miguel Cantu is a pathologist in Dallas, TX and is affiliated with the a University of Texas Southwestern. He received his medical degree from McGovern Medical School. He completed residency in Anatomic and Clinical Pathology and Hematopathology fellowship at New York Presbyterian-Weill Cornell and Molecular Genetic Pathology fellowship at UTSW.
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Molecular Genetic Pathology, 2021 - 2022
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematopathology, 2020 - 2021
- New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 2016 - 2020
- McGovern Medical School at UTHealthClass of 2016
Certifications & Licensure
- TX State Medical License 2022 - 2025
- NY State Medical License 2020 - 2022
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematology
- American Board of Pathology Molecular Genetic Pathology
- American Board of Pathology Pathology - Molecular Genetic
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- Genomic and Clinicopathological Characterization of CRLF2-Rearranged Mixed Phenotype Acute Leukemia.Lina Han, Ruifang Zheng, Franklin Fuda, Miguel D Cantu, Prasad Koduru
Pediatric Blood & Cancer. 2025-03-01 - Clinicopathologic and Molecular Characterization of NUP98-Rearranged Acute Leukemias.Sujata Sajjan, Estelle E Oertling, Franklin Fuda, Jeffrey Gagan, Prasad Koduru
International Journal of Laboratory Hematology. 2025-01-21 - Impact of myelodysplasia-related mutations on 2022 European LeukemiaNet genetic risk classification in de novo acute myeloid leukemia with normal karyotype.Srija Shanker, Robert P Hasserjian, Yazan Madanat, Olga K Weinberg, Miguel D Cantu
American Journal of Hematology. 2025-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: